International Biotechnology Trust (LSE:IBT) Debt-to-Equity : 0.10 (As of Feb. 2024)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Debt-to-Equity?

International Biotechnology Trust's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was £0.00 Mil. International Biotechnology Trust's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was £27.67 Mil. International Biotechnology Trust's Total Stockholders Equity for the quarter that ended in Feb. 2024 was £286.51 Mil. International Biotechnology Trust's debt to equity for the quarter that ended in Feb. 2024 was 0.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for International Biotechnology Trust's Debt-to-Equity or its related term are showing as below:

LSE:IBT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.06 Max: 0.17
Current: 0.1

During the past 13 years, the highest Debt-to-Equity Ratio of International Biotechnology Trust was 0.17. The lowest was 0.00. And the median was 0.06.

LSE:IBT's Debt-to-Equity is ranked better than
68.77% of 1015 companies
in the Asset Management industry
Industry Median: 0.19 vs LSE:IBT: 0.10

International Biotechnology Trust Debt-to-Equity Historical Data

The historical data trend for International Biotechnology Trust's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Debt-to-Equity Chart

International Biotechnology Trust Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Debt-to-Equity

Get a 7-Day Free Trial

0.06

0.07

0.14

0.12

International Biotechnology Trust Semi-Annual Data
	Aug14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Debt-to-Equity	Get a 7-Day Free Trial															0.17	0.14	0.08	0.12	0.10

Competitive Comparison of International Biotechnology Trust's Debt-to-Equity

For the Asset Management subindustry, International Biotechnology Trust's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust's Debt-to-Equity Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Debt-to-Equity falls into.

International Biotechnology Trust Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

International Biotechnology Trust's Debt to Equity Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	32.474)	/	270.317
	=	0.12

International Biotechnology Trust's Debt to Equity Ratio for the quarter that ended in Feb. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	27.669)	/	286.509
	=	0.10

International Biotechnology Trust (LSE:IBT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

International Biotechnology Trust Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust (LSE:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

IBTl:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines